摘要
目的 检测和分析获得性纯红细胞再生障碍(PRCA)患者T淋巴细胞亚群的分布,评估患者免疫功能状态及环孢素对T淋巴细胞亚群的影响.方法 采用流式细胞术对22例获得性PRCA患者和22名健康对照者外周血标本进行T淋巴细胞亚群检测,检测PRCA患者在应用以环孢素为基础的免疫抑制方案治疗3个月前后的淋巴细胞亚群变化.结果 22例患者治疗后17例血象恢复正常(3例骨髓象也恢复正常),总有效率95.5%(21/22)(基本治愈3例,缓解14例,进步4例,无效1例).获得性PRCA患者组的Th细胞(CD3+ CD4+)、Th/Ts比值均低于健康对照组,Ts细胞(CD3+ CD8+)的表达高于健康对照组,差异有统计学意义(P<0.05).治疗3个月后Th细胞、Th/Ts比值较前升高,Ts细胞较前治疗下降,差异均有统计学意义(均P< 0.05).结论 获得性PRCA患者T淋巴细胞亚群失调导致其细胞免疫功能紊乱,环孢素可改善获得性PRCA患者的T淋巴细胞亚群失衡,是治疗该疾病的有效方法之一,疗效显著,且不良反应较轻。
Objective To detect and analyse acquired pure red cell aplasia (PRCA) T lymphocyte subsets distribution and to assess its condition and cyclosporine immune function of T lymphocytes subsets.Methods Flow cytometry was applicated to detect peripheral blood T lymphocyte subsets of acquired PRCA patients before and after 3 months of treatment with cyclosporine-based immunosuppressive regimen and normal controls.Results Among 22 patients,17 cases of blood returning normal (three cases of bone marrow returning normal),the total effective rate was 95.5 % (3 cases of cure,14 cases of remission,4 cases of improvement,1 case of ineffectiveness).Th (CD3+ CD4+) cells and Th/Ts ratios in acquired PRCA patient group were lower than those in the normal control group,while Ts (CD3+ CD8+) cells was higher than that in the normal control group,the differences were statistically significant (P 〈 0.05).After 3 months of treatment,Th cells and Th/Ts ratio were higher than those before,and Ts cells were decreased compared with the previous (P 〈 0.05).Conclusion Disorders of T lymphocyte subsets in acquired PRCA patients lead to immune dysfunction,however,cyclosporine can improve T lymphocyte subsets in patients with imbalance,which is an effective way to treat the disease with significant curative effect and mild adverse reactions.
出处
《肿瘤研究与临床》
CAS
2015年第8期526-528,共3页
Cancer Research and Clinic